Item Number | Policy/Procedure | Date Posted | Comment Period Closed | Status | Document Links |
---|---|---|---|---|---|
2019-LHCC-45 | Court Ordered Services | 12/27/19 | 2/10/20 | Approved | Court Ordered Services |
2019-LHCC-48 | EPSDT Personal Care Services | 12/26/19 | 2/9/20 | Approved | EPSDT Personal Care Services |
2019-UHC-200 | Ablative Treatment for Spinal Pain (for Louisiana Only) | 12/23/19 | 2/6/20 | Completed | Ablative Treatment for Spinal Pain (for Louisiana Only) |
2019-UHC-201 | Apheresis (for Louisiana Only) | 12/23/19 | 2/6/20 | Completed | Apheresis (for Louisiana Only) |
2019-UHC-202 | Balloon Sinus Ostial Dilation (for Louisiana Only) | 12/23/19 | 2/6/20 | Completed | Balloon Sinus Ostial Dilation (for Louisiana Only) |
2019-UHC-203 | Breast Reduction Surgery (for Louisiana Only) | 12/23/19 | 2/6/20 | Pending | Breast Reduction Surgery (for Louisiana Only) |
2019-UHC-204 | Cardiac Event Monitoring | 12/23/19 | 2/6/20 | Completed | Cardiac Event Monitoring |
2019-UHC-205 | Computed Tomographic Colonography | 12/23/19 | 2/6/20 | Completed | Computed Tomographic Colonography |
2019-UHC-206 | Electric Tumor Treatment Field Therapy | 12/23/19 | 2/6/20 | Completed | Electric Tumor Treatment Field Therapy |
2019-UHC-207 | Electrical Stimulation for the Treatment of Pain and Muscle Rehabilitation | 12/23/19 | 2/6/20 | Completed | Electrical Stimulation for the Treatment of Pain and Muscle Rehabilitation |
2019-UHC-208 | Epidural Steroid and Facet Injections for Spinal Pain | 12/23/19 | 2/6/20 | Completed | Epidural Steroid and Facet Injections for Spinal Pain |
2019-UHC-210 | Epiduroscopy, Epidural Lysis of Adhesions and Functional Anesthetic Discography (for Louisiana Only) | 12/23/19 | 2/6/20 | Completed | Epiduroscopy, Epidural Lysis of Adhesions and Functional Anesthetic Discography (for Louisiana Only) |
2019-UHC-211 | Fecal Calprotectin Testing (for Louisiana Only) | 12/23/19 | 2/6/20 | Completed | Fecal Calprotectin Testing (for Louisiana Only) |
2019-UHC-212 | Functional Endoscopic Sinus Surgery (FESS) (for Louisiana Only) | 12/23/19 | 2/6/20 | Completed | Functional Endoscopic Sinus Surgery (FESS) (for Louisiana Only) |
2019-UHC-213 | Genetic Testing for Hereditary Cancer (for Louisiana Only) | 12/23/19 | 2/6/20 | Completed | Genetic Testing for Hereditary Cancer (for Louisiana Only) |
2019-UHC-214 | Molecular Oncology Testing for Cancer Diagnosis, Prognosis, and Treatment Decisions (for Louisiana Only) | 12/23/19 | 2/6/20 | Completed | Molecular Oncology Testing for Cancer Diagnosis, Prognosis, and Treatment Decisions (for Louisiana Only) |
2019-UHC-215 | Bone or Soft Tissue Healing and Fusion Enhancement Products | 12/23/19 | 2/6/20 | Completed | Bone or Soft Tissue Healing and Fusion Enhancement Products |
2019-UHC-216 | DME | 12/23/19 | 2/6/20 | Completed | DME |
2019-UHC-217 | Omnibus Codes | 12/23/19 | 2/6/20 | Completed | Omnibus Codes |
2019-UHC-218 | Pharmacogenetic Testing | 12/23/19 | 2/6/20 | Completed | Pharmacogenetic Testing |
2019-UHC-219 | Articular Defect Repairs | 12/23/19 | 2/6/20 | Completed | Articular Defect Repairs |
2019-UHC-220 | Prolotherapy and Platelet Rich Plasma Therapies | 12/23/19 | 2/6/20 | Completed | Prolotherapy and Platelet Rich Plasma Therapies |
2019-UHC-221 | Prosthetic Devices, Specialized, Microprocessor or Myoelectric Limbs | 12/23/19 | 2/6/20 | Completed | Prosthetic Devices, Specialized, Microprocessor or Myoelectric Limbs |
2019-UHC-222 | Skin and Soft Tissue Substitutes (for Louisiana Only) | 12/23/19 | 2/6/20 | Completed | Skin and Soft Tissue Substitutes (for Louisiana Only) |
2019-UHC-223 | Vagus and Trigeminal Nerve Stimulation | 12/23/19 | 2/6/20 | Completed | Vagus and Trigeminal Nerve Stimulation |
2019-UHC-224 | Visual Information Processing Evaluation and Orthoptic and Vision Therapy | 12/23/19 | 2/6/20 | Completed | Visual Information Processing Evaluation and Orthoptic and Vision Therapy |
2019-UHC-247 | Negative Pressure Wound Therapy | 12/23/19 | 2/6/20 | Completed | Negative Pressure Wound Therapy |
2019-LHCC-138 | Appropriate UM Professionals | 12/27/19 | 2/10/20 | Approved | Appropriate UM Professionals |
2019-LHCC-139 | UM Program Description | 12/27/19 | 2/10/20 | Approved | UM Program Description |
2019-ABH-118 | Prior Authorization of PDHC | 12/18/19 | 2/1/20 | Approved | Prior Authorization of PDHC |
2019-ABH-117 | Multi-Systemic Therapy | 12/18/19 | 2/1/20 | Approved | Multi-Systemic Therapy |
2019-ABH-116 | Crisis Intervention Services | 12/18/19 | 2/1/20 | Approved | Crisis Intervention Services |
2019-HBL-128 | Continuing Crisis Intervention Services | 12/18/19 | 2/1/20 | Approved | Continuing Crisis Intervention Services |
2019-UHC-125 | Certification of Need for PRTFs | 12/16/19 | 1/30/20 | Approved | Certification of Need for PRTFs |
2019-PHARM-3 | Mayzent | 12/12/19 | 1/26/20 | Approved | Mayzent |
2019-PHARM-4 | Reclast | 12/12/19 | 1/26/20 | Approved | Reclast |
2019-PHARM-5 | Vyndaquel Criteria | 12/12/19 | 1/26/20 | Approved | Vyndaquel Criteria |
2019-PHARM-6 | Spinraza PA Form | 12/12/19 | 1/26/20 | Approved | Spinraza PA Form |
2019-PHARM-7 | Rinvoq | 12/12/19 | 1/26/20 | Approved | Rinvoq |
2019-PHARM-8 | Pamidronate Disodium | 12/12/19 | 1/26/20 | Approved | Pamidronate Disodium |
2019-PHARM-9 | Neudexta | 12/12/19 | 1/26/20 | Approved | Neudexta |
2019-PHARM-10 | Gattex | 12/12/19 | 1/26/20 | Approved | Gattex |
2019-PHARM-11 | Epidiolex | 12/12/19 | 1/26/20 | Approved | Epidiolex |
2019-PHARM-12 | Enzyme Replacement Therapy | 12/12/19 | 1/26/20 | Approved | Enzyme Replacement Therapy |
2019-PHARM-13 | Cablivi Criteria | 12/12/19 | 1/26/20 | Approved | Cablivi Criteria |
2019-PHARM-14 | Acthar Gel Criteria | 12/12/19 | 1/26/20 | Approved | Acthar Gel Criteria |
2019-PHARM-16 | Nucala | 12/12/19 | 1/26/20 | Approved | Nucala |
2019-PHARM-17 | POS Posting for November 2019 DUR | 12/12/19 | 1/26/20 | Approved | POS Posting for November 2019 DUR |
2019-ABH-122 | Out of State Outpatient CCR | 12/11/19 | 1/25/20 | Approved | Out of State Outpatient CCR |
2019-UHC-123 | Prior Authorization FAQ 2019 | 12/11/19 | 1/25/20 | Approved | Prior Authorization FAQ 2019 |
2019-LHCC-111 | Functional Family Therapy – Child Welfare | 12/11/19 | 1/25/20 | Approved | Functional Family Therapy – Child Welfare |
2019-HBL-142 | Med CAT II Changes Provider Letter | 12/11/19 | 1/25/20 | Approved | Med CAT II Changes Provider Letter |
2019-UHC-124 | Intensive Outpatient Process Change Proposal | 12/11/19 | 1/25/20 | Approved | Intensive Outpatient Process Change Proposal |
2019-HBL-229 | Special Health Care Needs Population | 12/6/19 | 1/20/20 | Approved | Special Health Care Needs Population |
2019-LHCC-134 | ED Diversion PP | 12/6/19 | 1/20/20 | Approved | ED Diversion PP |
2019-LHCC-136 | Oversight of Delegated UM | 12/6/19 | 1/20/20 | Approved | Oversight of Delegated UM |
2019-LHCC-137 | UM Communication Services | 12/6/19 | 1/20/20 | Approved | UM Communication Services |
2019-LHCC-140 | Timeliness of UM Decisions | 12/6/19 | 1/20/20 | Approved | Timeliness of UM Decisions |
2019-LHCC-141 | Enteral and Oral Nutrition | 12/6/19 | 1/20/20 | Approved | Enteral and Oral Nutrition |
2019-HBL-228 | Informal Reconsideration | 12/5/19 | 1/19/20 | Completed | Informal Reconsideration |
2019-HBL-240 | Appeal Policy Provider Manual Updates | 12/5/19 | 1/19/20 | Approved | Appeal Policy Provider Manual Updates |
2019-LHCC-40 | Provider policy revisions - Provider Orientation | 12/5/19 | 1/19/20 | Completed | Provider policy revisions - Provider Orientation |
2019-LHCC-41 | Provider policy revisions - Provider Visit Schedule | 12/5/19 | 1/19/20 | Completed | Provider policy revisions - Provider Visit Schedule |
2019-LHCC-43 | Quality Policy revisions - Appeals Process | 12/5/19 | 1/19/20 | Completed | Quality Policy revisions - Appeals Process |
2019-LHCC-47 | Clinical policy revision requests - Authorization for Second Clinical Opinions | 12/5/19 | 1/19/20 | Completed | Clinical policy revision requests - Authorization for Second Clinical Opinions |
2019-LHCC-55 | LHCC revisions to Operations policies - Call Line PP Provider Services Calls Hotline | 12/5/19 | 1/19/20 | Completed | LHCC revisions to Operations policies - Call Line PP Provider Services Calls Hotline |
2019-LHCC-105 | Appeal of UM Decisions | 12/5/19 | 1/19/20 | Completed | Appeal of UM Decisions |
2019-LHCC-108 | Womens Health Services | 12/5/19 | 1/19/20 | Completed | Womens Health Services |
2019-LHCC-109 | Clinical Decision Criteria and Application | 12/5/19 | 1/19/20 | Completed | Clinical Decision Criteria and Application InterQual Corporate Policy Variances |
2019-LHCC-110 | Continued Stay and Discharge Planning | 12/5/19 | 1/19/20 | Completed | Continued Stay and Discharge Planning |
2019-LHCC-133 | Care Management Program Description | 12/5/19 | 1/19/20 | Approved | Care Management Program Description |
2019-UHC-225 | Radiology CPT Codes | 12/5/19 | 1/19/20 | Approved | Radiology CPT Codes |
2019-UHC-238 | Breast Reconstruction Not Following Mastectomy | 12/5/19 | 1/19/20 | Approved | Breast Reconstruction Not Following Mastectomy |
2019-UHC-239 | Breast Reconstruction Post Mastectomy | 12/5/19 | 1/19/20 | Approved | Breast Reconstruction Post Mastectomy |
2019-HPA-4 | Reimbursement of Opioid Use Disorder Treatment in Opioid Treatment Programs | 11/26/19 | 1/10/20 | Complete | HPA: Reimbursement of Opioid Use Disorder Treatment in Opioid Treatment Programs |
2019-Enbrel-1 | Recommendation to Change Status of Enbrel of Medicaid PDL | 11/25/19 | 1/9/20 | Approved | Recommendation to Change Status of Enbrel of Medicaid PDL |
2019-HPA-3 | Telemedicine/Telehealth Billing Changes for RHCs and FQHCs | 11/25/19 | 1/10/20 | Complete | HPA: Telemedicine/Telehealth Billing Changes for RHCs and FQHCs |
2019-IB-1 | Telemedicine/Telehealth Billing Changes for RHCs and FQHCs | 11/25/19 | 1/10/20 | Complete | IB: Telemedicine/Telehealth Billing Changes for RHCs and FQHCs |
2019-HPA-2 | CLIA Number Information: Revised | 11/15/19 | 12/30/19 | Complete | Revised HPA: CLIA Number Information |
2019-Chisholm-1 | Chisholm Compliance MCO User Process Manual | 10/29/19 | 12/13/19 | Complete | Chisholm Compliance MCO User Process Manual |
2019-Healthy Blue-95 | MHR PSR Provider Bulletin | 10/24/19 | 12/8/19 | Approved | MHR PSR Provider Bulletin |
2019-LHCC-54 | PCP Selection Change | 10/14/19 | 11/28/19 | Approved | PCP Selection Change |
2019-PHARM-2 | MCO Criteria Changes | 10/13/19 | 11/27/19 | Complete | MCO Criteria Changes |
2019-LHCC-25 | UM Communication Services | 10/11/19 | 11/25/19 | Approved | UM Communication Services |
2019-Healthy Blue-49 | PA Req N Supervision for Hyperbaric O2 | 10/11/19 | 11/25/19 | Approved | PA Req N Supervision for Hyperbaric O2 |
2019-Healthy Blue-96 | ICD-10 Coding Tips Sheet Flier | 10/10/19 | 11/24/19 | Approved | ICD-10 Coding Tips Sheet Flier |
2019-Healthy Blue-80 | SBIRT Filter Update | 10/10/19 | 11/24/19 | Approved | SBIRT Flier Update |
2019 Healthy Blue-92 | CCRT Configuration - PA Changes - Blue RFRF | 10/10/19 | 11/24/19 | Approved | CCRT Configuration - PA Changes - Blue RFRF |
2019-Healthy Blue-94 | SUD Criteria for Prior Authorization | 10/10/19 | 11/24/19 | Approved | SUD Criteria for Prior Authorization |
2019-Healthy Blue-38 | WAVE CG DME 46 Pneumatic | 10/4/19 | 11/18/19 | Approved | WAVE CG DME 46 Pneumatic |
2019-PHARM-1 | Suspending Agents | 9/25/19 | 11/9/19 | Approved | Suspending Agents |
2019-PDL-1 | Advair - PDL Changes | 9/25/19 | 11/9/19 | Pending | PDL Changes |
2019-UHC-29 | Pharmacogenetic Testing | 9/20/19 | 11/4/19 | Approved | Pharmacogenetic Testing |
2019-UHC-27 | UHC Prior Authorization LA Effective 9.1.19 | 9/13/19 | 10/28/19 | Approved | UHC Prior Authorization LA Effective 9.1.19 |
2019-HBL-20 | Semi Annual Cost of Care Review | 9/13/19 | 10/28/19 | Approved | BLA-NL-0148-19 |
2019-DUR-1 | Pharmacy Drug Utilization Review (DUR) Criteria | 9/13/19 | 10/28/19 | Complete | Pharmacy DUR Criteria effective 11/1 and 12/1 |
2019-IB-1 | Proposed retirement of Informational Bulletin 16-1 | 9/12/19 | 10/27/19 | Complete | IB 16-1 |
2019-SCG-2 | LDH stopped using self-reported data in 2018; the 416 reports are generated from MCO encounter data. | 9/10/19 | 10/25/19 | Complete | MCO System Companion Guide, pg. 117 |
2019-SCG-1 | Edit 472 disposition to be changed from "E" to "D" [deny]. | 9/10/19 | 10/25/19 | Complete | MCO System Companion Guide, pg. 128 |
2019-HPA-1 | Severe Combined Immunodeficiency (SCID) | 8/27/19 | 10/11/19 | Complete | Severe Combined Immunodeficiency (SCID) |
Medicaid Managed Care Policies & Procedures Archive (2019)
"Policy or procedure" shall mean a requirement governing the administration of managed care organizations specific to billing guidelines, medical management and utilization review guidelines, case management guidelines, claims processing guidelines and edits, grievance and appeals procedures and process, other guidelines or manuals containing pertinent information related to operations and pre-processing claims, and core benefits and services.
Below are items previously posted for public comment in 2019:
Related Info